PeptideDB

ABBV-154

ABBV-154

CAS No.:

ABBV-154 is an anti-TNF antibody-drug conjugate (ADC). ABBV-154 is composed of the humanized antibody Adalimumab and the
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

ABBV-154 is an anti-TNF antibody-drug conjugate (ADC). ABBV-154 is composed of the humanized antibody Adalimumab and the glucocorticoid receptor modulator. ABBV-154 can be used in the research of rheumatoid arthritis, Crohn's disease and polymyalgia rheumatica.

Physicochemical Properties


Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vivo ABBV-154 (ADC 11) (0-80 mg/kg; subcutaneous injection; once every two weeks; 13 weeks) showed good stability in cynomolgus monkeys, with a stable DAR of 4.0[1].
References

[1]. Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC). J Med Chem. 2023 Sep 14;66(17):12544-12558.


Solubility Data